Bearish Analyst Comments on Dendreon (DNDN)
Tweet Send to a Friend
Analysts at Brean Capital are negative on pharmaceutical company Dendreon Corp. (NASDAQ: DNDN) and today maintained a Sell rating on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE